Amgen, Inc.

Amgen, Inc. logo
🇺🇸United States
Ownership
Public
Established
1980-01-01
Employees
26.7K
Market Cap
$175.6B
Website
http://www.amgen.com
Clinical Trials
Related News

Osteonecrosis of the Jaw (ONJ) and Infection Among Nordic Cancer Patients Treated With XGEVA™ or Zoledronic Acid

First Posted Date
2013-10-22
Last Posted Date
2023-06-22
Lead Sponsor
Amgen
Target Recruit Count
2560
Registration Number
NCT01967160

Study to Assess the Impact on Calcium Levels When Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) Switch From Cinacalcet to Etelcalcetide

Phase 3
Completed
Conditions
Hyperparathyroidism, Secondary
Interventions
Drug: Etelcalcetide
First Posted Date
2013-08-30
Last Posted Date
2018-10-17
Lead Sponsor
Amgen
Target Recruit Count
158
Registration Number
NCT01932970
Locations
🇺🇸

Research Site, Hampton, Virginia, United States

Evaluating Etanercept Use in Patients With Moderate to Severe Rheumatoid Arthritis Who Have Lost Response to Adalimumab

First Posted Date
2013-08-23
Last Posted Date
2018-01-30
Lead Sponsor
Amgen
Target Recruit Count
90
Registration Number
NCT01927757
Locations
🇵🇷

Research Site, Caguas, Puerto Rico

A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.

Phase 1
Completed
Conditions
Asthma
Interventions
Drug: AMG 282
Drug: AMG 282 Matching Placebo
First Posted Date
2013-08-23
Last Posted Date
2016-12-14
Lead Sponsor
Amgen
Target Recruit Count
70
Registration Number
NCT01928368
Locations
🇺🇸

Research Site, Seattle, Washington, United States

Efficacy and Safety Study of ABP 980 Compared With Trastuzumab in Women With HER2-positive Early Breast Cancer

First Posted Date
2013-07-17
Last Posted Date
2019-08-07
Lead Sponsor
Amgen
Target Recruit Count
725
Registration Number
NCT01901146
Locations
🇬🇧

Research Site, Peterborough, England, United Kingdom

Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease

First Posted Date
2013-06-05
Last Posted Date
2024-12-17
Lead Sponsor
Amgen
Target Recruit Count
88
Registration Number
NCT01868997
Locations
🇺🇸

Jules Stein Eye Institute at UCLA, Los Angeles, California, United States

🇮🇹

Fondazione Ca' Granda Ospedale Policlinico Graves GO Center, Milan, Italy

🇮🇹

University of Pisa, Azienda Ospedaliera, Pisa, Italy

and more 12 locations

Medical Records Review to Describe the Patterns of KRAS Testing and Vectibix Use in Europe

Completed
Conditions
Metastatic Colorectal Cancer
Interventions
Other: Other
First Posted Date
2013-02-15
Last Posted Date
2022-09-10
Lead Sponsor
Amgen
Target Recruit Count
439
Registration Number
NCT01791361
Locations
🇸🇪

Research Site, Västerås, Sweden

Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis

First Posted Date
2012-11-26
Last Posted Date
2020-03-10
Lead Sponsor
Amgen
Target Recruit Count
643
Registration Number
NCT01732770
Locations
🇪🇸

Research Site, Madrid, Spain

European Physician Survey of EGFR Inhibitor Prescribing Patterns

First Posted Date
2012-07-30
Last Posted Date
2022-09-09
Lead Sponsor
Amgen
Target Recruit Count
453
Registration Number
NCT01652833

Trial Assessing Long Term USe of PCSK9 Inhibition in Subjects With Genetic LDL Disorders

Phase 2
Completed
Conditions
Severe Familial Hypercholesterolemia
Interventions
Biological: Evolocumab
First Posted Date
2012-06-20
Last Posted Date
2024-05-28
Lead Sponsor
Amgen
Target Recruit Count
300
Registration Number
NCT01624142
Locations
🇬🇧

Research Site, Manchester, United Kingdom

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy